April 16, 2014 3:47 PM ET

Pharmaceuticals

Company Overview of Sinapis Pharma, Inc.

Company Overview

Sinapis Pharma, Inc, a drug development company, engages in the discovery and development of methamphetamine, an intravenous neuroprotective agent for the treatment of acute stroke and brain injury. The company was incorporated in 2009 and is based in Jacksonville, Florida.

3610 Holly Grove Avenue

Jacksonville, FL 32217

United States

Founded in 2009

Phone:

904-619-0043

Fax:

904-619-0034

Key Executives for Sinapis Pharma, Inc.

Chief Executive Officer
Age: 66
Founder and Chairman
Age: 52
Chief Scientific Officer
Consultant
Age: 81
Compensation as of Fiscal Year 2013.

Similar Private Companies By Industry

Company Name Region
MaxThera, Inc. United States
Vensun Pharmaceuticals, Inc. United States
Surgical Technologies, Inc. United States
AZTherapies, Inc. United States
Sigma Global Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sinapis Pharma, Inc., please visit www.sinapispharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.